603439.SH
GuiZhou SanLi Pharmaceutical Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 12.12
−2.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 37.78x
- P/E 2027E
- 34.87x
- P/E 2028E
- —
- P/S forward
- 6.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- 105.82x
- PEG TTM
- —
- Price / book
- 3.42x
- Price / sales
- 3.28x
- Price / cash flow
- 28.42x
Enterprise value
- Enterprise value
- CNY 6.0B
- EV / sales
- 3.58x
- EV / EBITDA
- 43.63x
- EV / EBIT
- 87.31x
- Market cap
- CNY 4.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026